AstraZeneca PLCLong
AZN entry opportunity
AZN offers a good entry at the $60 level with a well calculated risk 1:3.
The further discussion about the next vaccination, the upcoming winter and the oversold RSI should trigger the stock into profit pretty well.
The further discussion about the next vaccination, the upcoming winter and the oversold RSI should trigger the stock into profit pretty well.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.